![](/img/cover-not-exists.png)
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of an Oral Formulation of DS-1040, an Inhibitor of the Activated Form of Thrombin-Activatable Fibrinolysis Inhibitor, in Healthy Subjects
Zhou, Jin, Limsakun, Tharin, Yin, Ophelia, Warren, Vance, Zamora, Cynthia, Atiee, George, Kochan, Jarema, Pav, Joseph, Kobayashi, Fumiaki, Vashi, Vijay, Dishy, VictorLanguage:
english
Journal:
The Journal of Clinical Pharmacology
DOI:
10.1002/jcph.1474
Date:
June, 2019
File:
PDF, 237 KB
english, 2019